- Stocks Telegraph
- Posts
- 29 Nov - ST - Morning Newsletter (with survey at top and bottom)
29 Nov - ST - Morning Newsletter (with survey at top and bottom)
4 Active Stocks in Today Pre-Market Session!
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!Futures for US stock indices are rising on Tuesday following Asian stock markets that closed mostly in positive territory, according to trading data and an analyst's commentary.Futures for the Dow Jones Industrial Index (DJIA) are growing by 0.04%, to 33886 points, futures for the NASDAQ high-tech index - by 0.42%, to 11664.5 points, for the S&P 500 broad market index - by 0.23%, up to 3979 points.Investor optimism on Tuesday is due to hopes for a recovery in economic growth in China. Traders expect the country's authorities to ease anti-COVID restrictive measures after protests the day before.Moreover, the markets are optimistic about a slowdown in rate hikes, according to the expert.
The Top 5 NASDAQ Stocks to Own for New Year 2023
Even in the worst of times, markets have rallied back. Just as they always have. So, if you're thinking of quitting the market, don't. There are plenty of bargains and hot investing ideas to jump on. In fact, here are five of our best ideas for 2023.
Sponsored
Today Top Movers
NanoVibronix Inc. (NAOV) stock soared 15.33% to $0.7299 in the pre-market trading following the receipt of FDA 510(k) premarket clearance for PainShield Plus.
Bilibili Inc. (NASDAQ: BILI) shares are trading up 8.5% at $13.66 at the time of writing after releasing Q3 2022 financial results.
Kala Pharmaceuticals Inc. (KALA) grew over 19.54% at $6.73 in pre-market trading today. The company announced the submission of an investigational new drug application to the FDA for KPI-012 for the treatment of Persistent Corneal Epithelial Defect (PCED).
ContraFect Corporation (CFRX), a Biotechnology company, rose about 8.14% at $0.1568 in pre-market trading Tuesday after declaring that ANSM has authorized its Clinical Trial Application (CTA) for the study of intra-articularly administered exebacase for Exebacase in Prosthetic Joint Infections.
NEW Investor Report: The Perfect Lithium Opportunity
Electric vehicle demand is expected to jump 96% between 2021 and 2040. Meanwhile, the International Energy Agency sees a lithium shortage looming. The world needs lithium. New investment is needed, and fast. One company may be poised to deliver. Details in this FREE REPORT. This overlooked company has projects in the "Lithium Triangle," home to over 75% of the world's supply.
Sponsored
Top Upgrades & Downgrades
Deutsche Bank turned bullish on Canadian Pacific Railway Limited (CP), upgrading the stock to "Buy" and assigning a $98 price target, representing potential upside of 21.84% from Monday's close.
United Parcel Service Inc. (UPS) has won the favor of Deutsche Bank's equity research team. The firm upgraded the shares from Hold to Buy and moved their price target to $220, suggesting 22.28% additional upside for the stock.
NovoCure Limited (NVCR) received an upgrade from analysts at Wells Fargo, who also set their one-year price target on the stock to $89. They changed their rating on NVCR to Overweight from Equal Weight in a recently issued research note.
Earlier Tuesday Morgan Stanley reduced its rating on CinCor Pharma Inc. (CINC) stock to Equal-Weight from Overweight and assigned the price target to $22.
Baird analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Darden Restaurants Inc. (DRI) has been changed to Neutral from Outperform and the new price target is set at $150.
Analysts at Keybanc downgraded Roku Inc. (ROKU)'s stock to Sector Weight from Overweight Tuesday.
The Smart Way to Get Insanely Rich in the 2022-23 Gold Bull Market
A brand-new gold bull market is emerging as nervous investors continue to flock to the safety of the yellow metal in the face of rampant inflation. Yet, the biggest gains won't be in gold...they'll be in select small-cap gold stocks with the inside track on the NEXT major discoveries.
Sponsored
Latest Insider Activity
Alphabet Inc. (GOOG) Director MATHER ANN announced the sale of shares taking place on Nov 25 at $98.48 for some 360 shares. The total came to more than $35453.0.
Kinder Morgan Inc. (KMI) V.P. (President, Terminals) Schlosser John W sold on Nov 25 a total 1,500 shares at $18.70 on average. The insider’s sale generated proceeds of almost $28050.0.
Cosmos Holdings Inc. (COSM) Chief Executive Officer Siokas Grigorios declared the purchase of shares taking place on Nov 28 at $0.62 for some 801,261 shares. The transaction amount was around $0.5 million.
Canoo Inc. (GOEV) Executive Chairman and CEO Aquila Tony bought on Nov 21 a total 4,504,505 shares at $1.11 on average. The purchase cost the insider an estimated $5.0 million.
Rare Metal Discovery: Tiny Sub-$0.25 Stock Set to Deliver Gains
Smart investors are blowing away Wall Street's so-called experts on clean energy stocks. And with the green-energy revolution in full-swing, the near-term gains could be absolutely life-changing. The timing is dead-on accurate with this sub-US$0.25 stock securing an ultra-rare clean energy resource on North American soil that China doesn't want us to have.
Sponsored
Important Earnings
Top US earnings releases scheduled for today include Kanzhun Limited (NASDAQ: BZ). It will announce its Sep 2022 financial results. The company is expected to report earnings of $0.08 per share from revenues of $160.29M in the three-month period.
Analysts expect The Carlyle Group Inc. (NASDAQ: CG) to report a net income (adjusted) of $0.97 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2022 is predicted to come in at $1.03B.
The Bank of Nova Scotia (BNS), due to announce earnings before the market opens today, is expected to report earnings of $1.46 per share from revenues of $6.02B recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.